UBS Group
SRZN icon

UBS Group’s Surrozen SRZN Stock Holding History

UBS Group’s Portfolio SRZN Stock Details SRZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$758K Buy
29,229
+7,982
+38% +$219K ﹤0.01% 5946
2026
Q1 		$619K Buy
21,247
+21,188
+35,912% +$508K ﹤0.01% 5919
2025
Q4 		$1.33K Buy
+59
New +$955 ﹤0.01% 9622
2025
Q3 		– Sell
-259
Closed -$2.31K – 10892
2025
Q2 		$2.31K Buy
259
+62
+31% +$567 ﹤0.01% 9485
2025
Q1 		$2.3K Buy
197
+165
+516% +$1.92K ﹤0.01% 9362
2024
Q4 		$459 Buy
+32
New +$340 ﹤0.01% 9461
2024
Q3 		– Sell
-12,027
Closed -$132K – 10036
2024
Q2 		$132K Buy
+12,027
New +$124K ﹤0.01% 5973
2024
Q1 		– Sell
-46
Closed -$432 – 9984
2023
Q4 		$432 Sell
46
-271
-85% -$1.89K ﹤0.01% 8660
2023
Q3 		$2.33K Buy
+317
New +$3.01K ﹤0.01% 7724
2023
Q2 		– Sell
-1,017
Closed -$9.18K – 9602
2023
Q1 		$9.18K Buy
1,017
+892
+714% +$10.9K ﹤0.01% 7670
2022
Q4 		$1.09K Buy
125
+73
+140% +$1.54K ﹤0.01% 9960
2022
Q3 		$2K Buy
+52
New +$2.19K ﹤0.01% 9777
2021
Q3 		– Sell
-106
Closed -$16K – 10056
2021
Q2 		$16K Sell
106
-128
-55% -$19K ﹤0.01% 7590
2021
Q1 		$34K Buy
+234
New +$35.7K ﹤0.01% 6904

Other funds holding SRZN

CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group's SRZN Position: Q2 2026 in Review

UBS Group increased its Surrozen (SRZN) stake by 38% in Q2 2026, buying an estimated $219K and bringing the position to 29,229 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #5946.

UBS Group first reported a position in SRZN in Q1 2021 and has held it in 14 quarters since. 70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

  • UBS Group held 29,229 shares of Surrozen worth $758K as of Q2 2026.
  • UBS Group bought 7,982 Surrozen shares in Q2 2026, an estimated $219K.
  • Surrozen made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5946 holding.
  • UBS Group first reported a position in Surrozen in Q1 2021 and has held it in 14 quarters since.
  • 70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.